BioSpace News Archive

Biotech Bay

SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024

SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Barclays 26th Annual Global Healthcare Conference in Miami.

March 4, 2024
·
1 min read
Genetown

Biogen Highlights New Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™) 2024 Annual Meeting

Biogen Inc. (Nasdaq: BIIB) announced it will present new data from its Alzheimer’s disease (AD) portfolio at the upcoming International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2024), taking place March 5-9 in Lisbon, Portugal and virtually.

March 4, 2024
·
5 min read
Biotech Bay

Akero Therapeutics Announces Proposed Public Offering of Common Stock - March 04, 2024

Akero Therapeutics, Inc. announced that it has commenced an underwritten public offering of $300.0 million of shares of its common stock.

March 4, 2024
·
4 min read
Business

Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a corporate update.

March 4, 2024
·
13 min read
Drug Development

Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants

Vaxcyte, Inc. today announced the completion of enrollment in its Phase 2 study evaluating VAX-24, a broad-spectrum, carrier-sparing 24-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive pneumococcal disease (IPD), in healthy infants.

March 4, 2024
·
10 min read
Ascendis Pharma to Participate in the Leerink Partners Global Biopharma Conference 2024

Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the Leerink Partners Global Biopharma Conference 2024 on Monday, March 11, 2024 at 2:00 p.m. ET in Miami, Florida.

March 4, 2024
·
3 min read
BioMidwest

NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage

NeurAxis, Inc., a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, announced receipt of Blue Cross and Blue Shield of Kansas City policy coverage for approximately one million lives.

March 4, 2024
·
3 min read
Biotech Bay

Scilex Holding Company Launches New Website to Showcase Growing Portfolio of Non-Opioid Products and Pipeline Information Updates

Scilex Holding Company announced the launch of its redesigned website showcasing the Company’s growing portfolio of non-opioid pain management therapeutics.

March 4, 2024
·
7 min read
Business

VGXI Welcomes Michael Stewart as New Chief Operating Officer

VGXI, Inc., a leading contract developer and manufacturer specializing in nucleic acid biopharmaceuticals, including gene therapies, DNA vaccines, and RNA medicines, proudly announces the appointment of Michael Stewart as its new Chief Operating Officer.

March 4, 2024
·
3 min read
Neurophet introduces AI-powered brain imaging analysis technology at AD/PD 2024

Neurophet, an artificial intelligence (AI) solution company for brain disease, announced its participation in the international conference on Alzheimer’s and Parkinson’s diseases and related neurological disorders (AD/PD 2024).

March 4, 2024
·
3 min read